KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy
NCT00033813
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
NETWORK
Sponsor class
Conditions
Muscular Dystrophy, Duchenne
Interventions
DRUG:
Oxatomide (tinset)
Sponsor
Cooperative International Neuromuscular Research Group